Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sangamo Therapeutics (SGMO) Non Operating Income (2024 - 2025)

Sangamo Therapeutics (SGMO) has 4 years of Non Operating Income data on record, last reported at $107000.0 in Q3 2025.

  • For Q3 2025, Non Operating Income rose 148.42% year-over-year to $107000.0; the TTM value through Sep 2025 reached -$3.8 million, down 251.55%, while the annual FY2016 figure was $887000.0, 105.8% up from the prior year.
  • Non Operating Income reached $107000.0 in Q3 2025 per SGMO's latest filing, up from -$2.5 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $2.1 million in Q1 2024 and bottomed at -$2.5 million in Q2 2025.